AlphAIAlphAI — Financial news for AI agents
BenzingaJUN 123 min read$GNLN

Marijuana Stock Movers For June 12, 2025 - Blueberries Medical (OTC:BBRRF), CNBX Pharmaceuticals (OTC:CNBX)

Greenlane Hldgs GNLN shares closed up 90.91% at $0.02 Cann Group CNGGF shares closed up 53.85% at $0.01 Leafbuyer Techs LBUY shares closed up 16.88% at $0.03 Affinor Growers RSSFF shares closed up 15.99% at $0.05 Mexco Energy MXC shares closed up 6.13% at $8.48

Original reporting
Benzinga · Benzinga Insights
Published Jun 12, 2025, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2025, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$GNLN
Bullish
medium confidence
Mentioned
$GNLN
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$GNLNBullishMed
01

Why it matters

The recent price movements reflect speculative trading and sector optimism, but lack of substantial news warrants caution.

02

Market read

The sector is experiencing a bullish phase with increased trading activity, especially in OTC stocks, driven by sector optimism and speculative interest.

03

What to watch

Lack of fundamental catalysts or news to support sustained growth; potential for profit-taking and volatility.

Timing: Immediate to short-term (next few days)

Background

The cannabis sector has experienced increased investor interest, partly driven by legalization trends and sector-specific news.

Company-level read

Ticker impact

$GNLNBullishMedium confidence
Context

High relevance due to a 53.85% increase in share price and positive sentiment.

Expected impact

Likely short-term upward movement, potential for profit-taking after rapid gains.

Evidence & confidence

The sharp increase suggests strong buying interest, possibly driven by news or market speculation, but low absolute share price indicates high volatility and risk.

Market effects

Sector

Positive sentiment across cannabis and biotech sectors, indicating investor optimism.

Regional

Potentially increased trading activity in North American markets, especially OTC segments.

Global

Limited; primarily regional OTC market movements with minimal global influence.

Counterpoint

What could challenge this read

The recent surge may be a short-term speculative spike; caution is advised as prices could revert.

Key entities

  • Company
    Greenlane Holdings

    A distributor of cannabis accessories and products.

  • Company
    Cann Group

    An Australian cannabis cultivator and manufacturer.

  • Company
    CNBX Pharmaceuticals

    A biotech company focused on cannabis-based pharmaceuticals.

  • Company
    Affinor Growers

    An agricultural biotech company involved in cannabis cultivation.

  • Company
    22nd Century Group

    A biotech company developing plant-based products.

Read at source← All news

Related articles

AUG 14
$GNLNMed

Greenlane Holdings, Inc. (GNLN): Results of Operations and Financial Condition

Greenlane Holdings, Inc. (GNLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 August 14, 2026 Greenlane Reports Second Quarter 2026 Financial Results ● Total Operating Expenses Reduced Approximately 37% Sequentially in the Second Quarter 2026 from the First Quarter 2026, Reflecting Continued Cost Alignment ● BERA Holdings of Approximately 81.3

SEC EDGAR 8-K6 min
JUL 8
$GNLNMed

Berachain Activates PoL Next; Greenlane Announces Additional Cost-Reduction Initiatives and Reaffirms Long-Term BERA Accumulation Strategy

Greenlane Holdings (Nasdaq: GNLN) reported cost-reduction steps and reiterated its long-term BERA accumulation strategy after aligning expenses with its digital-asset treasury model. It said it reduced headcount to 13 from 23 and cut cost of sales and facility costs. Greenlane also said the Berachain Foundation activated PoL Next to direct more yield to BERA holders; any benefit to Greenlane is uncertain. Greenlane reported holding 81.6M BERA as of July 7, 2026.

manilatimes.net6 min
SEP 27
$CIFRHighAI 9/10

Cipher Digital reports AI lab commitment to enter lease

Cipher Digital Inc. (NASDAQ: CIFR) announced a binding commitment for a second ten-year lease at its Texas data center, expected to generate $5.2B in incremental revenue, bringing total contracted revenue to over $9B. The lease follows an initial agreement with Fluidstack and is expected to commence after the first hall's delivery in Q4 2026. The company also listed potential risks including performance, delays, and financing.

mugglehead.com2 min
SEP 26
$MSFTMed

Wall Street ends higher on AI stocks buying

Wall Street rose on Friday, led by AI-related stocks like Microsoft (+3.7%), Qualcomm (+4%), and Dell (+5%). Akamai (+3.2%) gained after an $11.6B deal with Anthropic. Meta fell 3.3% despite a 13% weekly gain. S&P 500 (+0.51%), Nasdaq (+0.48%), and Dow (+0.93%) all closed higher.

tribune.com.pk2 min
SEP 26
$BAMedAI 8/10

U.S. Army awards Boeing $636.1 million for Apache helicopter support, lifting sustainment contract value above $1.1 billion through 2029

The U.S. Army awarded Boeing a $636.1 million contract for Apache helicopter support, increasing the total contract value to over $1.1 billion through 2029. The funding covers repairs, parts supply, and logistics management. Boeing will oversee 80 suppliers and 480 parts, aiming to improve readiness and reduce costs. Work will be done in Mesa, Arizona, and is expected to conclude in 2029.

defence-industry.eu1 min
SEP 26
$ACHRHighAI 8/10

The Pentagon Is Buying eVTOLs. Here's Which Stock Wins the Defense Money.

The Pentagon has awarded contracts to Archer Aviation (up to $142M) and Joby Aviation (up to $131M) for eVTOL aircraft. Archer's Midnight aircraft is already delivered, while Joby is adapting to DoD's shift toward hybrid and autonomous tech. Archer's partnership with Anduril and potential acquisition of Boeing's Insitu may give it an edge in defense contracts.

finance.yahoo.com3 min